| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/25/2013 | WO2013033366A3 Methods and compositions for promoting glucose homeostasis |
| 04/25/2013 | WO2013030218A4 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 04/25/2013 | WO2013019091A3 A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |
| 04/25/2013 | WO2013016544A3 Templated islet cells and small islet cell clusters for diabetes treatment |
| 04/25/2013 | WO2012177444A3 Glucagon/glp-1 receptor co-agonists |
| 04/25/2013 | WO2012177443A3 Glucagon/glp-1 receptor co-agonists |
| 04/25/2013 | WO2012174285A3 Inhibitor probes for imaging sodium-glucose cotransporters in health and disease |
| 04/25/2013 | WO2012174280A3 Methods and compositions for modulating myofibroblast activities |
| 04/25/2013 | WO2012174164A3 Agonists of gpr131 and uses thereof |
| 04/25/2013 | WO2012173819A3 Anti-cd3 therapies |
| 04/25/2013 | US20130102898 Liposome including elastin-like polypeptides and use thereof |
| 04/25/2013 | US20130102619 2-pyridyloxy-4-nitrile orexin receptor antagonists |
| 04/25/2013 | US20130102616 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 04/25/2013 | US20130102573 2-methylene-vitamin d analogs and their uses |
| 04/25/2013 | US20130102555 Method of treating diabetes |
| 04/25/2013 | US20130101610 Therapeutic Uses of CD137 in Treating Autoimmune Disease |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | US20130101580 Compositions and methods for prolonging lifespan |
| 04/25/2013 | US20130101557 Recombinant Adenovirus Having Anti-Angiogenesis Activity |
| 04/25/2013 | CA2853168A1 Use of whey protein micelles for improving insulin profile in diabetic patients |
| 04/25/2013 | CA2853165A1 Use of whey protein micelles for enhancing energy expenditure and satiety |
| 04/25/2013 | CA2852939A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
| 04/25/2013 | CA2852937A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
| 04/25/2013 | CA2852936A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
| 04/25/2013 | CA2852615A1 Novel substituted imidazopyrimidines as gpbar1 receptor modulators |
| 04/25/2013 | CA2851589A1 Bicyclic heterocyclic compound |
| 04/24/2013 | EP2584041A1 Composition for preventing or treating diabetes comprising nad glycohydrolase inhibitor as active ingredient |
| 04/24/2013 | EP2583972A1 Therapeutic agent for inflammatory diseases containing adenosine n1-oxide as active ingredient |
| 04/24/2013 | EP2583968A1 Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses |
| 04/24/2013 | EP2583965A1 Heterocyclic ring compound |
| 04/24/2013 | EP2583693A1 Pharmaceutical composition utilizing pancreatic cell proliferation factor |
| 04/24/2013 | EP2583675A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| 04/24/2013 | EP2583565A1 Use of whey protein micelles for enhancing energy expenditure and satiety |
| 04/24/2013 | EP2583564A1 Use of whey protein micelles for improving insulin profile in diabetic patients |
| 04/24/2013 | EP2583562A1 Use of whey protein micelles for infants at risk of obesity or diabetes |
| 04/24/2013 | EP2582715A2 Growth hormone secretatogue receptor antagonists and uses thereof |
| 04/24/2013 | EP2582706A1 3-oxo-3,9-dihydro-1h-chromeno[2,3-c]pyrroles as glucokinase activators |
| 04/24/2013 | EP2582698A1 Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
| 04/24/2013 | EP2582367A2 Methods and systems for modulating hormones and related methods, agents and compositions |
| 04/24/2013 | CN1935141B Use of descarboethoxyloratadine or its pharmaceutical salts in preparing medicine for treating urticaria |
| 04/24/2013 | CN103069000A Eggshell membrane solubilization method using enzymes |
| 04/24/2013 | CN103068826A New azacyclic compounds |
| 04/24/2013 | CN103068821A 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 04/24/2013 | CN103068806A 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
| 04/24/2013 | CN103068444A Use of deuterium depleted water for the treatment of insulin resistance |
| 04/24/2013 | CN103068400A Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| 04/24/2013 | CN103068395A Therapeutic agent for disease |
| 04/24/2013 | CN103068380A Methods and systems for modulating hormones and related methods, agents and compositions |
| 04/24/2013 | CN103060335A Optimization and high-efficiency expression of insulin aspart precursor gene |
| 04/24/2013 | CN103060159A Chrysanthemum wine |
| 04/24/2013 | CN103059165A Polysaccharide acylate and preparation method thereof |
| 04/24/2013 | CN103059154A Fungal glucan oligomer chrome complex and preparation method thereof |
| 04/24/2013 | CN103059152A Isolates of hedysari polybotrys polysaccharide 3 and application thereof |
| 04/24/2013 | CN103059127A GLP-1 analogs, and preparation method and application thereof |
| 04/24/2013 | CN103059014A Novel heteroaryl amino derivative |
| 04/24/2013 | CN103058976A Quercetin alpha crystal-form substance, preparation method thereof, pharmaceutical composition thereof and purpose thereof |
| 04/24/2013 | CN103058972A Phenyl C-glucoside derivatives containing cyclohexane structure as well as preparation method and application thereof |
| 04/24/2013 | CN103055313A Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders |
| 04/24/2013 | CN103055273A Three-original ecology tracing stasis-clearing detoxification health traditional Chinese medicine and preparation method thereof |
| 04/24/2013 | CN103055259A Boxthorn leaf health tea for reducing fat and losing weight and preparation method thereof |
| 04/24/2013 | CN103055245A Preparation method of traditional Chinese medicine treating hematoporphyria |
| 04/24/2013 | CN103055199A Fat-reducing buccal tablets |
| 04/24/2013 | CN103055198A Medicine for treating diabetes mellitus and preparation method thereof |
| 04/24/2013 | CN103055176A Traditional Chinese medicine for treating diabetes mellitus and preparation method thereof |
| 04/24/2013 | CN103055156A Compound dendrobium huoshanense, cistanche and ganoderma extract and production process thereof |
| 04/24/2013 | CN103055154A Hypoglycemic dark green tea for dredging collaterals and preparation method thereof based on theory of homeostasis reconstruction |
| 04/24/2013 | CN103055153A Traditional Chinese medicine formula for treating kidney hypohydration, stomach heat, anti-inflammation and consumptive thirst |
| 04/24/2013 | CN103055150A Chinese herbal medicine for treating kidney water deficiency and stomach heat flaring-up diabetes |
| 04/24/2013 | CN103055133A Traditional Chinese medicine for treating hypertension and hyperlipidemia and preparation method of traditional Chinese medicine |
| 04/24/2013 | CN103055129A Traditional Chinese medical preparation for treating hyperlipidemia |
| 04/24/2013 | CN103055114A Traditional Chinese medicine formula for treating diabetes |
| 04/24/2013 | CN103055099A Freeze-dried pharmaceutical composition for preventing and treating obesity |
| 04/24/2013 | CN103055097A Freeze-dried dioscorea opposita for treating diabetes mellitus |
| 04/24/2013 | CN103055096A Application for freeze-dried Chinese yam in medicine preparation |
| 04/24/2013 | CN103055063A Aloe and pearl powder convenient granule |
| 04/24/2013 | CN103055057A Plant weight-losing and fat-reducing composite compatible to L-carnitine |
| 04/24/2013 | CN103055056A Traditional Chinese medicine composition with auxiliary blood fat reduction function and preparation method of traditional Chinese medicine composition |
| 04/24/2013 | CN103055028A Medicine for treating early microangiopathy of diabetes mellitus and preparation method thereof |
| 04/24/2013 | CN103055026A Pharmaceutical composition for treating obesity |
| 04/24/2013 | CN103055025A Medicine composition for preventing and treating obesity |
| 04/24/2013 | CN103055017A Freeze-dried rehmannia for treating diabetes mellitus |
| 04/24/2013 | CN103054972A Method of extracting oleanolic acid and ursolic acid from pawpaw |
| 04/24/2013 | CN103054971A Preparation process of blood-sugar-reducing and lipid-lowering potentilla discolor medicinal granules |
| 04/24/2013 | CN103054923A Method and device for carrying out dynamic and continuous circulating extraction on total triterpenoid saponin in yerbadetajo herb medicinal material |
| 04/24/2013 | CN103054920A Purslane for preventing and treating obesity |
| 04/24/2013 | CN103054917A Application for freeze-dried purslane in medicine preparation |
| 04/24/2013 | CN103054912A Taxus chinensis extractive with blood sugar reduction effect, as well as preparation method and application thereof |
| 04/24/2013 | CN103054907A Propolis flavonoid extractive and preparation method thereof |
| 04/24/2013 | CN103054898A Application for montmorillonite in preparation of medicine for treating obesity |
| 04/24/2013 | CN103054895A Medicine composition for preventing and treating obesity |
| 04/24/2013 | CN103054892A Gracillin-hydroxypropyl-beta-cyclodextrin inclusion compound and preparation method thereof |
| 04/24/2013 | CN103054890A Application of cornuside in preparing pharmaceuticals used to cure diabetic nephropathy |
| 04/24/2013 | CN103054888A Solid oral preparation containing acarbose and atorvastatin calcium and preparation method of solid oral preparation |
| 04/24/2013 | CN103054878A Application of alisol A23-acetic acid ester for preparing medicine for treating hyperlipidemia |
| 04/24/2013 | CN103054877A Composition containing alisol A and application of composition containing alisol A on medicine |
| 04/24/2013 | CN103054866A Application of chloroxine in preparing anti-angiogenesis medicine |
| 04/24/2013 | CN103054865A Stable niacin simvastatin sustained-release tablet and preparation method thereof |
| 04/24/2013 | CN103054856A Solid oral preparation containing metformin hydrochloride and atorvastatin calcium |
| 04/24/2013 | CN103054848A Pharmaceutical composition for preventing or treating cardiovascnlar and cerebrovascular diseases |
| 04/24/2013 | CN103054845A Dyslipidemia prevention and treatment |